 | |
| Company type | Société Anonyme |
|---|---|
| Traded as | LSE: NCYT Euronext: ALNOV |
| Industry | Biotechnology |
| Founded | 2006 |
| Headquarters | Camberley, Surrey, United Kingdom |
| Key people | David Allmond (CEO) |
| Products | In vitro and molecular diagnostics |
| Subsidiaries | |
| Website | www.novacyt.com |
Novacyt Group (/ˈnoʊvəsaɪt/ NOH-və-syte) is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's (WHO) Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory.
References
- "Offices". Novacyt. Retrieved 1 February 2020.
- "How dangerous is the coronavirus and how does it spread?". Financial Times. Retrieved 1 February 2020.
- "Novacyt launches research-only Wuhan virus test". The Standard (Hong Kong). Retrieved 1 February 2020.
- "Annual Report and Accounts for the year ended December 2018" (PDF). Novacyt. Retrieved 1 February 2020.
- "Healthcare Company Novacyt Launches New Coronavirus Test". The New York Times. Retrieved 1 February 2020.
- "Novacyt shares jump 32% on launch of coronavirus test". CNBC. Retrieved 1 February 2020.
- "Chandlers Ford company Primerdesign launch novel coronavirus test". Southern Daily Echo. Retrieved 1 February 2020.
- "Novacyt in prime position with coronavirus test". The Times. Retrieved 8 February 2020.
- "WHO approves Novacyt's coronavirus testing kit". The Jerusalem Post. Retrieved 8 April 2020.
- "WHO lists two COVID-19 tests for emergency use". World Health Organization. Retrieved 10 April 2020.
- "Novacyt's Covid-19 diagnostic test gets OK for WHO procurement". London South East. Retrieved 8 April 2020.
- "Novacyt joins AstraZeneca and GSK in UK effort on COVID-19 testing". The Pharma Letter. Retrieved 8 April 2020.
External links
 | This French corporation or company article is a stub. You can help Misplaced Pages by expanding it. |